A Rapid Screening Method of Candidate Probiotics for Inflammatory Bowel Diseases and the Anti-inflammatory Effect of the Selected Strain Bacillus smithii XY1

Changing Global Epidemiology of Inflammatory Bowel Diseases—Sustaining Healthcare Delivery into the 21st Century

(2020) Ashwin N. Ananthakrishnan et al.   Clinical Gastroenterology and Hepatology

Synbiotic supplementation with prebiotic green banana resistant starch and probiotic Bacillus coagulans spores ameliorates gut inflammation in mouse model of inflammatory bowel diseases

(2020) Tanvi Shinde et al.   EUROPEAN JOURNAL OF NUTRITION

The microbiome and inflammatory bowel disease

(2020) Kerri L. Glassner et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Beneficial effects resulting from oral administration of Escherichia coli Nissle 1917 on a chronic colitis model

(2020) E.L.S. Souza et al.   Beneficial Microbes

Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies

(2019) Paulo José Basso et al.   Frontiers in Pharmacology

Zebrafish modeling of intestinal injury, bacterial exposures, and medications defines epithelial in vivo responses relevant to human inflammatory bowel disease

(2019) Ling-shiang Chuang et al.   Disease Models & Mechanisms

A potential probiotic Chromobacterium aquaticum with bacteriocin-like activity enhances the expression of indicator genes associated with nutrient metabolism, growth performance and innate immunity against pathogen infections in zebrafish (Danio rerio)

(2019) Che-Chun Yi et al.   FISH & SHELLFISH IMMUNOLOGY

The zebrafish as a model for gastrointestinal tract–microbe interactions

(2019) Erika M. Flores et al.   CELLULAR MICROBIOLOGY

Automatic hemolysis identification on aligned dual-lighting images of cultured blood agar plates

(2018) Mattia Savardi et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Deficiency in class III PI3-kinase confers postnatal lethality with IBD-like features in zebrafish

(2018) Shaoyang Zhao et al.   Nature Communications

How to select a probiotic? A review and update of methods and criteria

(2018) Gilberto Vinícius de Melo Pereira et al.   BIOTECHNOLOGY ADVANCES

Functional gastrointestinal symptoms in patients with inflammatory bowel disease: A clinical challenge

(2018) Jean-Frederic Colombel et al.   Clinical Gastroenterology and Hepatology

Aeromonas veronii and aerolysin are important for the pathogenesis of motile aeromonad septicemia in cyprinid fish

(2018) Chao Ran et al.   ENVIRONMENTAL MICROBIOLOGY

Impact of Lactobacillus casei BL23 on the Host Transcriptome, Growth and Disease Resistance in Larval Zebrafish

(2018) Chubin Qin et al.   Frontiers in Physiology

Food-Origin Lactic Acid Bacteria May Exhibit Probiotic Properties: Review

(2018) Dorota Zielińska et al.   Biomed Research International

A whole animal chemical screen approach to identify modifiers of intestinal neutrophilic inflammation

(2017) Stefan H. Oehlers et al.   FEBS Journal

Fecal Transplant in Inflammatory Bowel Disease

(2017) Alexander S. Browne et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

(2017) Siew C Ng et al.   LANCET

Gut microbiota and IBD: causation or correlation?

(2017) Josephine Ni et al.   Nature Reviews Gastroenterology & Hepatology

Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood

(2016) F Yan et al.   Mucosal Immunology

Efficacy of probiotic treatment withBifidobacterium longum 536for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial

(2015) Hiroyuki Tamaki et al.   Digestive Endoscopy

Salt-tolerant microorganisms potentially useful for bioleaching operations where fresh water is scarce

(2015) S.M. Rea et al.   MINERALS ENGINEERING

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial

(2014) Andreas Munk Petersen et al.   Journal of Crohns & Colitis

The past 10 years of gastroenterology and hepatology—reflections and predictions

(2014) Scott L. Friedman et al.   Nature Reviews Gastroenterology & Hepatology

Chemically Induced Intestinal Damage Models in Zebrafish Larvae

(2013) Stefan H. Oehlers et al.   Zebrafish

Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

(2012) Luke Jostins et al.   NATURE

The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish

(2011) S. H. Oehlers et al.   Disease Models & Mechanisms

A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis

(2011) Signe Wildt et al.   Journal of Crohns & Colitis

NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease

(2011) W Strober et al.   Mucosal Immunology

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

(2010) Antonio Tursi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

(2010) Harald Matthes et al.   BMC Complementary and Alternative Medicine

Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis

(2010) Siew C. Ng et al.   INFLAMMATORY BOWEL DISEASES

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

(2009) Ajit Sood et al.   Clinical Gastroenterology and Hepatology